FDA Approved: ZESTRIL — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for ZESTRIL (lisinopril) submitted by Upsher-Smith Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Heart Failure
• Hypertension
• Myocardial Infarction

Drugs mentioned

• Zestril (lisinopril)

Snippet

SUPPL AP for ZESTRIL (LISINOPRIL)